ibrutinib
Tyrosine Kinase Inhibitors
Common brand names
- Imbruvica
Approved use in
- Multiple Myeloma
- B-Cell Prolymphocytic Leukemia
- Chronic Lymphocytic Leukemia
- Mantle Cell Lymphoma
- Marginal Zone Lymphoma
- T-Cell Prolymphocytic Leukemia
- Waldenström's Macroglobulinemia
Information about use in B-Cell Prolymphocytic Leukemia
Information about use in Blood Cancer
Information about use in Chronic Lymphocytic Leukemia
Information about use in Mantle Cell Lymphoma
Information about use in Marginal Zone Lymphoma
Information about use in T-Cell Prolymphocytic Leukemia
Information about use in Waldenström's Macroglobulinemia